Atlas Trials

A Clinical Study of Chemoradiotherapy Sequential Fluzoparib in Pan-solid Tumors

Clinical trial NCT06055166 · UNKNOWN

Trial details

NCT number
NCT06055166
Sponsor
Chongqing University Cancer Hospital
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
PARP Inhibitor for Esophageal Squamous Cell Carcinoma
Start date
2023-11-01
Primary completion
2024-11-30
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.